Cost minimization analysis of two chemotherapy regimens in the treatment of colorectal cancer in a public reimbursement hospital in Brazil

Objective: To conduct a pharmacoeconomic evaluation between XELOX and mFOLFOX6 in the adjuvant and metastatic treatment of colorectal cancer from the perspective of a public reimbursement hospital. Methods: The cost minimization analysis was conducted for patients who started treatment in 2013 and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sara C. BOSCATO, Márcia R. GODOY, Isabela HEINECK
Formato: article
Lenguaje:EN
PT
Publicado: Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2021
Materias:
Acceso en línea:https://doaj.org/article/dcac267a47ea48cb9ed155b9b1f77a35
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!